NL7302817A - - Google Patents

Info

Publication number
NL7302817A
NL7302817A NL7302817A NL7302817A NL7302817A NL 7302817 A NL7302817 A NL 7302817A NL 7302817 A NL7302817 A NL 7302817A NL 7302817 A NL7302817 A NL 7302817A NL 7302817 A NL7302817 A NL 7302817A
Authority
NL
Netherlands
Application number
NL7302817A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US262903A external-priority patent/US3867380A/en
Priority claimed from US00289499A external-priority patent/US3855213A/en
Application filed filed Critical
Publication of NL7302817A publication Critical patent/NL7302817A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7302817A 1972-06-14 1973-02-28 NL7302817A (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US262903A US3867380A (en) 1971-02-18 1972-06-14 3-Heterocyclic thiomethylcephalosporins
US00289499A US3855213A (en) 1971-02-18 1972-09-15 3-heterocyclic thiomethyl-cephalosporins

Publications (1)

Publication Number Publication Date
NL7302817A true NL7302817A (no) 1973-12-18

Family

ID=26949532

Family Applications (2)

Application Number Title Priority Date Filing Date
NL7302817A NL7302817A (no) 1972-06-14 1973-02-28
NL7305206A NL7305206A (no) 1972-06-14 1973-04-13

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL7305206A NL7305206A (no) 1972-06-14 1973-04-13

Country Status (20)

Country Link
JP (2) JPS5518716B2 (no)
AR (1) AR197237A1 (no)
AT (1) AT324560B (no)
AU (1) AU464107B2 (no)
CA (2) CA1076560A (no)
CH (2) CH586709A5 (no)
DD (1) DD105238A5 (no)
DE (1) DE2316867C2 (no)
DK (1) DK142913B (no)
ES (2) ES412207A1 (no)
FI (1) FI56843C (no)
FR (2) FR2187298B1 (no)
GB (2) GB1363833A (no)
HU (1) HU168689B (no)
IE (2) IE37409B1 (no)
IL (1) IL42126A (no)
NL (2) NL7302817A (no)
PH (1) PH9941A (no)
PL (1) PL91074B1 (no)
SE (2) SE416472B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2211216A1 (no) * 1972-12-26 1974-07-19 Bristol Myers Co

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215942B1 (no) * 1973-01-31 1978-12-22 Bristol Myers Co
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
CA1074784A (en) * 1974-09-06 1980-04-01 Sumitomo Chemical Company N-ACYLAMINO-.alpha.-ARYLACETAMIDO CEPHALOSPORINS
JPS5346995A (en) * 1976-10-12 1978-04-27 Sangyo Kagaku Kenkyu Kyokai Antibacterial agents
NL162387C (nl) * 1977-09-06 1980-05-16 Gist Brocades Nv Werkwijze voor het bereiden van 6-(d-alpha-amino-p- -hydroxyfenylacetamido)penicillanzuur.
JPS6010226U (ja) * 1983-06-30 1985-01-24 松下電工株式会社 昇降装置
JPS6182606A (ja) * 1984-09-29 1986-04-26 東芝ライテック株式会社 昇降装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA698494B (en) * 1969-02-26 1971-07-28 Lilly Co Eli Sulfur-containing cephalosporing antibiotics
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2211216A1 (no) * 1972-12-26 1974-07-19 Bristol Myers Co

Also Published As

Publication number Publication date
DK142913C (no) 1981-09-28
IE37499B1 (en) 1977-08-03
FR2187298B1 (no) 1976-12-03
FR2187299A1 (no) 1974-01-18
JPS4954393A (no) 1974-05-27
FI56843B (fi) 1979-12-31
DE2316866B2 (de) 1976-10-07
IL42126A0 (en) 1973-06-29
FR2187299B1 (no) 1976-12-03
DE2316867C2 (de) 1982-05-19
SE404190B (sv) 1978-09-25
AT324560B (de) 1975-09-10
AU464107B2 (en) 1975-08-14
IL42126A (en) 1975-12-31
JPS5518716B2 (no) 1980-05-21
PL91074B1 (en) 1977-02-28
HU168689B (no) 1976-06-28
IE37409B1 (en) 1977-07-20
DE2316867A1 (de) 1974-01-03
DD105238A5 (no) 1974-04-12
CA1076560A (en) 1980-04-29
ES412207A1 (es) 1976-01-01
IE37499L (en) 1973-12-14
CA999293A (en) 1976-11-02
NL7305206A (no) 1973-12-18
JPS5953274B2 (ja) 1984-12-24
PH9941A (en) 1976-06-14
AU5234573A (en) 1974-08-22
AR197237A1 (es) 1974-03-22
FI56843C (fi) 1980-04-10
GB1358027A (en) 1974-06-26
DE2316866A1 (de) 1974-01-03
JPS4931689A (no) 1974-03-22
CH589093A5 (no) 1977-06-30
CH586709A5 (no) 1977-04-15
ES413501A1 (es) 1976-07-16
DK142913B (da) 1981-02-23
IE37409L (en) 1973-12-14
GB1363833A (en) 1974-08-21
SE416472B (sv) 1981-01-05
FR2187298A1 (no) 1974-01-18

Similar Documents

Publication Publication Date Title
JPS4914572U (no)
JPS4980583A (no)
CS150890B1 (no)
CS151834B1 (no)
CS152039B1 (no)
CS152733B1 (no)
CH570503A5 (no)
CH572410A5 (no)
BG18292A1 (no)
BG18373A1 (no)
BG18499A1 (no)
BG22072A3 (no)
CH1668773A4 (no)
CH315973A4 (no)
CH322372A4 (no)
CH561453A5 (no)
CH564321A5 (no)
CH564392A5 (no)
CH564448A5 (no)
CH565246A5 (no)
CH565301A5 (no)
CH585228A5 (no)
CH567798A5 (no)
CH569076A5 (no)
CH575633A5 (no)